Markets:

Overview

News

Currencies

International

Treasuries

Adicet Bio, Inc. - Common Stock (NQ:ACET)

8.770 +0.390 (+4.65%)

Streaming Delayed Price Updated: 10:25 AM EDT, Aug 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adicet Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023 ↗

March 19, 2024

ACET stock results show that Adicet Bio met analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Adicet Bio: Q4 Earnings Insights ↗

March 19, 2024

Via Benzinga

Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress

March 19, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

March 11, 2024

From Adicet Bio, Inc.

Via Business Wire

3 High-Risk Stocks That Could Pay Off in the Millions ↗

March 05, 2024

With the S&P 500 at record highs, betting on these high-risk stocks that could pay off is a tantalizing prospect at this time.

Via InvestorPlace

Topics Stocks

Wedbush Maintains Outperform Rating for Adicet Bio: Here's What You Need To Know ↗

November 09, 2023

Via Benzinga

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

February 29, 2024

From Adicet Bio, Inc.

Via Business Wire

7 Top-Tier Penny Stocks for a Smart Bet ↗

February 27, 2024

Unlock value in penny stocks amid bullish S&P 500 trends and shifting monetary policies, focusing on businesses with solid drivers

Via InvestorPlace

Topics Stocks

7 Biotech Penny Stocks on the Verge of Clinical Trial Victory ↗

February 25, 2024

Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.

Via InvestorPlace

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

February 05, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

January 31, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

January 25, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio, Inc. Announces Pricing of Public Offering

January 22, 2024

From Adicet Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 22, 2024

Via Benzinga

Adicet Bio, Inc. Announces Proposed Public Offering

January 22, 2024

From Adicet Bio, Inc.

Via Business Wire

IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data ↗

January 22, 2024

IN8bio (NASDAQ: INAB) is a biotechnology company that specializes in developing novel therapies based on gamma-delta T cells. Its innovative technology focuses on harnessing the potential of these...

Via Benzinga

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 09, 2024

Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 09, 2024

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

January 05, 2024

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.

Via Benzinga

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 04, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 04, 2024

Via Benzinga

Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024

January 04, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook

January 03, 2024

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

December 29, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting

December 10, 2023

From Adicet Bio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 08, 2023

Via Benzinga

Harnessing The Power Of Gamma-Delta T Cells In Cancer Therapy: IN8bio's Innovative Approach ↗

November 27, 2023

Why Are Gamma-Delta T Cells Important In Fighting Cancer?

Via Benzinga

Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates

November 08, 2023

From Adicet Bio, Inc.

Via Business Wire

Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference

November 07, 2023

From Adicet Bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.